439 results on '"Seemann, T"'
Search Results
2. Temporal development of the oral microbiome and prediction of early childhood caries
- Author
-
Dashper, S. G., Mitchell, H. L., Lê Cao, K.-A., Carpenter, L., Gussy, M. G., Calache, H., Gladman, S. L., Bulach, D. M., Hoffmann, B., Catmull, D. V., Pruilh, S., Johnson, S., Gibbs, L., Amezdroz, E., Bhatnagar, U., Seemann, T., Mnatzaganian, G., Manton, D. J., and Reynolds, E. C.
- Published
- 2019
- Full Text
- View/download PDF
3. Improved Genome Sequence of Australian Methicillin-Resistant Staphylococcus aureus Strain JKD6159
- Author
-
Newton, ILG, Wick, RR, Judd, LM, Monk, IR, Seemann, T, Stinear, TP, Newton, ILG, Wick, RR, Judd, LM, Monk, IR, Seemann, T, and Stinear, TP
- Abstract
Staphylococcus aureus strain JKD6159 represents a prominent community-acquired methicillin-resistant S. aureus (MRSA) clone in Australia. Here, we report an improved assembly of the original S. aureus JKD6159 genome sequence. By using deep sequencing with multiple technologies combined with carefully curated assembly and polishing, we believe the assembly to contain zero errors.
- Published
- 2023
4. Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria.
- Author
-
Mu, A, Klare, WP, Baines, SL, Ignatius Pang, CN, Guérillot, R, Harbison-Price, N, Keller, N, Wilksch, J, Nhu, NTK, Phan, M-D, Keller, B, Nijagal, B, Tull, D, Dayalan, S, Chua, HHC, Skoneczny, D, Koval, J, Hachani, A, Shah, AD, Neha, N, Jadhav, S, Partridge, SR, Cork, AJ, Peters, K, Bertolla, O, Brouwer, S, Hancock, SJ, Álvarez-Fraga, L, De Oliveira, DMP, Forde, B, Dale, A, Mujchariyakul, W, Walsh, CJ, Monk, I, Fitzgerald, A, Lum, M, Correa-Ospina, C, Roy Chowdhury, P, Parton, RG, De Voss, J, Beckett, J, Monty, F, McKinnon, J, Song, X, Stephen, JR, Everest, M, Bellgard, MI, Tinning, M, Leeming, M, Hocking, D, Jebeli, L, Wang, N, Ben Zakour, N, Yasar, SA, Vecchiarelli, S, Russell, T, Zaw, T, Chen, T, Teng, D, Kassir, Z, Lithgow, T, Jenney, A, Cole, JN, Nizet, V, Sorrell, TC, Peleg, AY, Paterson, DL, Beatson, SA, Wu, J, Molloy, MP, Syme, AE, Goode, RJA, Hunter, AA, Bowland, G, West, NP, Wilkins, MR, Djordjevic, SP, Davies, MR, Seemann, T, Howden, BP, Pascovici, D, Tyagi, S, Schittenhelm, RB, De Souza, DP, McConville, MJ, Iredell, JR, Cordwell, SJ, Strugnell, RA, Stinear, TP, Schembri, MA, Walker, MJ, Mu, A, Klare, WP, Baines, SL, Ignatius Pang, CN, Guérillot, R, Harbison-Price, N, Keller, N, Wilksch, J, Nhu, NTK, Phan, M-D, Keller, B, Nijagal, B, Tull, D, Dayalan, S, Chua, HHC, Skoneczny, D, Koval, J, Hachani, A, Shah, AD, Neha, N, Jadhav, S, Partridge, SR, Cork, AJ, Peters, K, Bertolla, O, Brouwer, S, Hancock, SJ, Álvarez-Fraga, L, De Oliveira, DMP, Forde, B, Dale, A, Mujchariyakul, W, Walsh, CJ, Monk, I, Fitzgerald, A, Lum, M, Correa-Ospina, C, Roy Chowdhury, P, Parton, RG, De Voss, J, Beckett, J, Monty, F, McKinnon, J, Song, X, Stephen, JR, Everest, M, Bellgard, MI, Tinning, M, Leeming, M, Hocking, D, Jebeli, L, Wang, N, Ben Zakour, N, Yasar, SA, Vecchiarelli, S, Russell, T, Zaw, T, Chen, T, Teng, D, Kassir, Z, Lithgow, T, Jenney, A, Cole, JN, Nizet, V, Sorrell, TC, Peleg, AY, Paterson, DL, Beatson, SA, Wu, J, Molloy, MP, Syme, AE, Goode, RJA, Hunter, AA, Bowland, G, West, NP, Wilkins, MR, Djordjevic, SP, Davies, MR, Seemann, T, Howden, BP, Pascovici, D, Tyagi, S, Schittenhelm, RB, De Souza, DP, McConville, MJ, Iredell, JR, Cordwell, SJ, Strugnell, RA, Stinear, TP, Schembri, MA, and Walker, MJ
- Abstract
Even in the setting of optimal resuscitation in high-income countries severe sepsis and septic shock have a mortality of 20-40%, with antibiotic resistance dramatically increasing this mortality risk. To develop a reference dataset enabling the identification of common bacterial targets for therapeutic intervention, we applied a standardized genomic, transcriptomic, proteomic and metabolomic technological framework to multiple clinical isolates of four sepsis-causing pathogens: Escherichia coli, Klebsiella pneumoniae species complex, Staphylococcus aureus and Streptococcus pyogenes. Exposure to human serum generated a sepsis molecular signature containing global increases in fatty acid and lipid biosynthesis and metabolism, consistent with cell envelope remodelling and nutrient adaptation for osmoprotection. In addition, acquisition of cholesterol was identified across the bacterial species. This detailed reference dataset has been established as an open resource to support discovery and translational research.
- Published
- 2023
5. A large outbreak of Campylobacter jejuni infection in a university college caused by chicken liver pâté, Australia, 2013
- Author
-
MOFFATT, C. R. M., GREIG, A., VALCANIS, M., GAO, W., SEEMANN, T., HOWDEN, B. P., and KIRK, M. D.
- Published
- 2016
6. Pathogenomics of Pasteurella multocida
- Author
-
Boyce, J. D., Seemann, T., Adler, B., Harper, M., Aktories, Klaus, editor, Orth, Joachim H.C., editor, and Adler, Ben, editor
- Published
- 2012
- Full Text
- View/download PDF
7. Second SARS-CoV-2 infections twelve months after initial infections in Australia, confirmed by genomic analysis.
- Author
-
Minko C., Haile F., Gu J., Kidd D., Cross M., Baptista M., Crouch S., Pierce A.B., Stuart R.L., Lane C.R., Johnson S., Sherry N.L., Sait M., Horan K., Ballard S.A., Wilmot M., Watt A., Crachi C., Seemann T., Howden B.P., Minko C., Haile F., Gu J., Kidd D., Cross M., Baptista M., Crouch S., Pierce A.B., Stuart R.L., Lane C.R., Johnson S., Sherry N.L., Sait M., Horan K., Ballard S.A., Wilmot M., Watt A., Crachi C., Seemann T., and Howden B.P.
- Published
- 2022
8. Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis
- Author
-
Sherry, NL, Gorrie, CL, Kwong, JC, Higgs, C, Stuart, RL, Marshall, C, Ballard, SA, Sait, M, Korman, TM, Slavin, MA, Lee, RS, Graham, M, Leroi, M, Worth, LJ, Chan, HT, Seemann, T, Grayson, ML, Howden, BP, Sherry, NL, Gorrie, CL, Kwong, JC, Higgs, C, Stuart, RL, Marshall, C, Ballard, SA, Sait, M, Korman, TM, Slavin, MA, Lee, RS, Graham, M, Leroi, M, Worth, LJ, Chan, HT, Seemann, T, Grayson, ML, and Howden, BP
- Abstract
BACKGROUND: Current microbiological methods lack the resolution to accurately identify multidrug-resistant organism (MDRO) transmission, however, whole genome sequencing can identify highly-related patient isolates providing opportunities for precision infection control interventions. We investigated the feasibility and potential impact of a prospective multi-centre genomics workflow for hospital infection control. METHODS: We conducted a prospective genomics implementation study across eight Australian hospitals over 15 months (2017,2018), collecting all clinical and screening isolates from inpatients with vanA VRE, MRSA, ESBL Escherichia coli (ESBL-Ec), or ESBL Klebsiella pneumoniae (ESBL-Kp). Genomic and epidemiologic data were integrated to assess MDRO transmission. FINDINGS: In total, 2275 isolates were included from 1970 patients, predominantly ESBL-Ec (40·8%) followed by MRSA (35·6%), vanA VRE (15·2%), and ESBL-Kp (8·3%).Overall, hospital and genomic epidemiology showed 607 patients (30·8%) acquired their MDRO in hospital, including the majority of vanA VRE (266 patients, 86·4%), with lower proportions of ESBL-Ec (186 patients, 23·0%), ESBL-Kp (42 patients, 26·3%), and MRSA (113 patients, 16·3%). Complex patient movements meant the majority of MDRO transmissions would remain undetected without genomic data.The genomics implementation had major impacts, identifying unexpected MDRO transmissions prompting new infection control interventions, and contributing to vanA VRE becoming a notifiable condition. We identified barriers to implementation and recommend strategies for mitigation. INTERPRETATION: Implementation of a multi-centre genomics-informed infection control workflow is feasible and identifies many unrecognised MDRO transmissions. This provides critical opportunities for interventions to improve patient safety in hospitals. FUNDING: Melbourne Genomics Health Alliance (supported by State Government of Victoria, Australia), and National Health and Medical
- Published
- 2022
9. Genomic characterisation reveals a dominant lineage of SARS-CoV-2 in Papua New Guinea
- Author
-
Palou, T, Wilmot, M, Duchene, S, Porter, A, Kemoi, J, Suarkia, D, Andersson, P, Watt, A, Sherry, N, Seemann, T, Sait, M, Turharus, C, Nguyen, S, Schlebusch, S, Thompson, C, McMahon, J, Vaccher, S, Lin, C, Esoram, D, Howden, BP, Susapu, M, Palou, T, Wilmot, M, Duchene, S, Porter, A, Kemoi, J, Suarkia, D, Andersson, P, Watt, A, Sherry, N, Seemann, T, Sait, M, Turharus, C, Nguyen, S, Schlebusch, S, Thompson, C, McMahon, J, Vaccher, S, Lin, C, Esoram, D, Howden, BP, and Susapu, M
- Abstract
The coronavirus disease pandemic has highlighted the utility of pathogen genomics as a key part of comprehensive public health response to emerging infectious diseases threats, however, the ability to generate, analyse, and respond to pathogen genomic data varies around the world. Papua New Guinea (PNG), which has limited in-country capacity for genomics, has experienced significant outbreaks of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with initial genomics data indicating a large proportion of cases were from lineages that are not well defined within the current nomenclature. Through a partnership between in-country public health agencies and academic organisations, industry, and a public health genomics reference laboratory in Australia a system for routine SARS-CoV-2 genomics from PNG was established. Here we aim to characterise and describe the genomics of PNG's second wave and examine the sudden expansion of a lineage that is not well defined but very prevalent in the Western Pacific region. We generated 1797 sequences from cases in PNG and performed phylogenetic and phylodynamic analyses to examine the outbreak and characterise the circulating lineages and clusters present. Our results reveal the rapid expansion of the B.1.466.2 and related lineages within PNG, from multiple introductions into the country. We also highlight the difficulties that unstable lineage assignment causes when using genomics to assist with rapid cluster definitions.
- Published
- 2022
10. AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic
- Author
-
Hoang, T, da Silva, AG, Jennison, A, Williamson, DA, Howden, BP, Seemann, T, Hoang, T, da Silva, AG, Jennison, A, Williamson, DA, Howden, BP, and Seemann, T
- Abstract
The COVID-19 pandemic has driven demand for integrated genomics, resulting in fast-tracked development of AusTrakka, Australia’s pathogen genomics platform. This facilitated rapid data sharing, democratised access to computational and bioinformatic resources and expertise, and achieved national real-time genomic surveillance.
- Published
- 2022
11. Optimising genomic approaches for identifying vancomycin-resistant Enterococcus faecium transmission in healthcare settings
- Author
-
Higgs, C, Sherry, NL, Seemann, T, Horan, K, Walpola, H, Kinsella, P, Bond, K, Williamson, DA, Marshall, C, Kwong, JC, Grayson, ML, Stinear, TP, Gorrie, CL, Howden, BP, Higgs, C, Sherry, NL, Seemann, T, Horan, K, Walpola, H, Kinsella, P, Bond, K, Williamson, DA, Marshall, C, Kwong, JC, Grayson, ML, Stinear, TP, Gorrie, CL, and Howden, BP
- Abstract
Vancomycin-resistant Enterococcus faecium (VREfm) is a major nosocomial pathogen. Identifying VREfm transmission dynamics permits targeted interventions, and while genomics is increasingly being utilised, methods are not yet standardised or optimised for accuracy. We aimed to develop a standardized genomic method for identifying putative VREfm transmission links. Using comprehensive genomic and epidemiological data from a cohort of 308 VREfm infection or colonization cases, we compared multiple approaches for quantifying genetic relatedness. We showed that clustering by core genome multilocus sequence type (cgMLST) was more informative of population structure than traditional MLST. Pairwise genome comparisons using split k-mer analysis (SKA) provided the high-level resolution needed to infer patient-to-patient transmission. The more common mapping to a reference genome was not sufficiently discriminatory, defining more than three times more genomic transmission events than SKA (3729 compared to 1079 events). Here, we show a standardized genomic framework for inferring VREfm transmission that can be the basis for global deployment of VREfm genomics into routine outbreak detection and investigation.
- Published
- 2022
12. Niche-specific genome degradation and convergent evolution shaping Staphylococcus aureus adaptation during severe infections
- Author
-
Giulieri, SG, Guerillot, R, Duchene, S, Hachani, A, Daniel, D, Seemann, T, Davis, JS, Tong, SYC, Young, BC, Wilson, DJ, Stinear, TP, Howden, BP, Giulieri, SG, Guerillot, R, Duchene, S, Hachani, A, Daniel, D, Seemann, T, Davis, JS, Tong, SYC, Young, BC, Wilson, DJ, Stinear, TP, and Howden, BP
- Abstract
During severe infections, Staphylococcus aureus moves from its colonising sites to blood and tissues and is exposed to new selective pressures, thus, potentially driving adaptive evolution. Previous studies have shown the key role of the agr locus in S. aureus pathoadaptation; however, a more comprehensive characterisation of genetic signatures of bacterial adaptation may enable prediction of clinical outcomes and reveal new targets for treatment and prevention of these infections. Here, we measured adaptation using within-host evolution analysis of 2590 S. aureus genomes from 396 independent episodes of infection. By capturing a comprehensive repertoire of single nucleotide and structural genome variations, we found evidence of a distinctive evolutionary pattern within the infecting populations compared to colonising bacteria. These invasive strains had up to 20-fold enrichments for genome degradation signatures and displayed significantly convergent mutations in a distinctive set of genes, linked to antibiotic response and pathogenesis. In addition to agr-mediated adaptation, we identified non-canonical, genome-wide significant loci including sucA-sucB and stp1. The prevalence of adaptive changes increased with infection extent, emphasising the clinical significance of these signatures. These findings provide a high-resolution picture of the molecular changes when S. aureus transitions from colonisation to severe infection and may inform correlation of infection outcomes with adaptation signatures.
- Published
- 2022
13. Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021
- Author
-
Hogarth, F, Coffey, P, Goddard, L, Lewis, S, Labib, S, Wilmot, M, Andersson, P, Sherry, N, Seemann, T, Howden, BP, Freeman, K, Baird, R, Hosegood, I, McDermott, K, Walsh, N, Polkinghorne, B, Marshall, C, Davies, J, Krause, V, Meumann, EM, Hogarth, F, Coffey, P, Goddard, L, Lewis, S, Labib, S, Wilmot, M, Andersson, P, Sherry, N, Seemann, T, Howden, BP, Freeman, K, Baird, R, Hosegood, I, McDermott, K, Walsh, N, Polkinghorne, B, Marshall, C, Davies, J, Krause, V, and Meumann, EM
- Abstract
Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with 2 repatriation flights from India to Australia in April 2021 indicated that 4 passengers transmitted SARS-CoV-2 to >11 other passengers. Results suggest transmission despite mandatory mask use and predeparture testing. For subsequent flights, predeparture quarantine and expanded predeparture testing were implemented.
- Published
- 2022
14. State-wide genomic epidemiology investigations of COVID-19 in healthcare workers in 2020 Victoria, Australia: Qualitative thematic analysis to provide insights for future pandemic preparedness
- Author
-
E. Watt, A, L. Sherry, N, Andersson, P, Lane, CR, Johnson, S, Wilmot, M, Horan, K, Sait, M, Ballard, SA, Crachi, C, Beck, DJ, Marshall, C, Kainer, MA, Stuart, R, McGrath, C, Kwong, JC, Bass, P, Kelley, PG, Crowe, A, Guy, S, Macesic, N, Smith, K, Williamson, DA, Seemann, T, Howden, BP, E. Watt, A, L. Sherry, N, Andersson, P, Lane, CR, Johnson, S, Wilmot, M, Horan, K, Sait, M, Ballard, SA, Crachi, C, Beck, DJ, Marshall, C, Kainer, MA, Stuart, R, McGrath, C, Kwong, JC, Bass, P, Kelley, PG, Crowe, A, Guy, S, Macesic, N, Smith, K, Williamson, DA, Seemann, T, and Howden, BP
- Abstract
BACKGROUND: COVID-19 has affected many healthcare workers (HCWs) globally. We performed state-wide SARS-CoV-2 genomic epidemiological investigations to identify HCW transmission dynamics and provide recommendations to optimise healthcare system preparedness for future outbreaks. METHODS: Genome sequencing was attempted on all COVID-19 cases in Victoria, Australia. We combined genomic and epidemiologic data to investigate the source of HCW infections across multiple healthcare facilities (HCFs) in the state. Phylogenetic analysis and fine-scale hierarchical clustering were performed for the entire dataset including community and healthcare cases. Facilities provided standardised epidemiological data and putative transmission links. FINDINGS: Between March-October 2020, approximately 1,240 HCW COVID-19 infection cases were identified; 765 are included here, requested for hospital investigations. Genomic sequencing was successful for 612 (80%) cases. Thirty-six investigations were undertaken across 12 HCFs. Genomic analysis revealed that multiple introductions of COVID-19 into facilities (31/36) were more common than single introductions (5/36). Major contributors to HCW acquisitions included mobility of staff and patients between wards and facilities, and characteristics and behaviours of patients that generated numerous secondary infections. Key limitations at the HCF level were identified. INTERPRETATION: Genomic epidemiological analyses enhanced understanding of HCW infections, revealing unsuspected clusters and transmission networks. Combined analysis of all HCWs and patients in a HCF should be conducted, supported by high rates of sequencing coverage for all cases in the population. Established systems for integrated genomic epidemiological investigations in healthcare settings will improve HCW safety in future pandemics. FUNDING: The Victorian Government, the National Health and Medical Research Council Australia, and the Medical Research Future Fund.
- Published
- 2022
15. Silver and gold modified plasmonic TiO 2 hybrid films for photocatalytic decomposition of ethanol under visible light
- Author
-
Veres, Á., Rica, T., Janovák, L., Dömök, M., Buzás, N., Zöllmer, V., Seemann, T., Richardt, A., and Dékány, I.
- Published
- 2012
- Full Text
- View/download PDF
16. Tracing Migration through Mudstone Top Seals: a Case Study from the Vienna Basin
- Author
-
Misch, D., primary, Vranjes-Wessely, S., additional, Körmös, S., additional, Shi, X., additional, Wolfgang, S., additional, Zamolyi, A., additional, Liu, B., additional, Seemann, T., additional, and Sachsenhofer, R.F., additional
- Published
- 2022
- Full Text
- View/download PDF
17. Second SARS-CoV-2 infections twelve months after initial infections in Australia, confirmed by genomic analysis.
- Author
-
Minko C., Haile F., Gu J., Kidd D., Cross M., Baptista M., Crouch S., Pierce A.B., Stuart R.L., Lane C.R., Johnson S., Sherry N.L., Sait M., Horan K., Ballard S.A., Wilmot M., Watt A., Crachi C., Seemann T., Howden B.P., Minko C., Haile F., Gu J., Kidd D., Cross M., Baptista M., Crouch S., Pierce A.B., Stuart R.L., Lane C.R., Johnson S., Sherry N.L., Sait M., Horan K., Ballard S.A., Wilmot M., Watt A., Crachi C., Seemann T., and Howden B.P.
- Published
- 2021
18. Accessible Platform for High-Throughput COVID-19 Molecular Diagnostics and Genome Sequencing Using a Repurposed 3D Printer for RNA Extraction.
- Author
-
Vandelannoote K., Buultjens A.H., Li L., Sharkey L.K., Herisse M., Pidot S.J., Hoang T., Howden B.P., Monk I.R., Seemann T., Lee J.Y.H., Stinear T.P., Vandelannoote K., Buultjens A.H., Li L., Sharkey L.K., Herisse M., Pidot S.J., Hoang T., Howden B.P., Monk I.R., Seemann T., Lee J.Y.H., and Stinear T.P.
- Abstract
The COVID-19 pandemic has exposed the dependence of diagnostic laboratories on a handful of large corporations with market monopolies on the worldwide supply of reagents, consumables, and hardware for molecular diagnostics. Global shortages of key consumables for RT-qPCR detection of SARS-CoV-2 RNA have impaired the ability to run essential, routine diagnostic services. Here, we describe a workflow for rapid detection of SARS-CoV-2 RNA in upper respiratory samples including nasal swabs and saliva, utilizing low-cost equipment and readily accessible reagents. Using repurposedCreality3D Ender-3three-dimensional (3D) printers, we built a semiautomated paramagnetic bead RNA extraction platform. The hardware for the system was built for $300 USD, and the material cost per reaction was $1 USD. Named the Ender VX500, instrument performance when paired with RT-qPCR for SARS-CoV-2 detection in nasal and saliva specimens was two virus copies per microliter. There was a high-performance agreement (assessed using 458 COVID-19 nasal swab specimens) with the Aptima SARS-CoV-2 assay run on the Hologic Panther, a commercial automated RNA extraction and detection platform. Inter- and intrainstrument precision was excellent (coefficients of variation (CoV) of 1.10 and 0.66-1.32%, respectively) across four instruments. The platform is scalable with throughput ranging from 23 specimens on a single instrument run by one user in 50 min to 364 specimens on four instruments run by four users in 190 min. Step-by-step instructions and protocols for building and running theEnder VX500have been made available without restriction.Copyright © 2021 The Authors. Published by American Chemical Society
- Published
- 2021
19. Genomic diversity of antimicrobial resistance in non-typhoidal Salmonella in Victoria, Australia.
- Author
-
Sia, CM, Baines, SL, Valcanis, M, Lee, DYJ, Gonçalves da Silva, A, Ballard, SA, Easton, M, Seemann, T, Howden, BP, Ingle, DJ, Williamson, DA, Sia, CM, Baines, SL, Valcanis, M, Lee, DYJ, Gonçalves da Silva, A, Ballard, SA, Easton, M, Seemann, T, Howden, BP, Ingle, DJ, and Williamson, DA
- Abstract
Non-typhoidal Salmonella (NTS) is the second most common cause of foodborne bacterial gastroenteritis in Australia with antimicrobial resistance (AMR) increasing in recent years. Whole-genome sequencing (WGS) provides opportunities for in silico detection of AMR determinants. The objectives of this study were two-fold: (1) establish the utility of WGS analyses for inferring phenotypic resistance in NTS, and (2) explore clinically relevant genotypic AMR profiles to third generation cephalosporins (3GC) in NTS lineages. The concordance of 2490 NTS isolates with matched WGS and phenotypic susceptibility data against 13 clinically relevant antimicrobials was explored. In silico serovar prediction and typing was performed on assembled reads and interrogated for known AMR determinants. The surrounding genomic context, plasmid determinants and co-occurring AMR patterns were further investigated for multidrug resistant serovars harbouring bla CMY-2, bla CTX-M-55 or bla CTX-M-65. Our data demonstrated a high correlation between WGS and phenotypic susceptibility testing. Phenotypic-genotypic concordance was observed between 2440/2490 (98.0 %) isolates, with overall sensitivity and specificity rates >98 % and positive and negative predictive values >97 %. The most common AMR determinants were bla TEM-1, sul2, tet(A), strA-strB and floR. Phenotypic resistance to cefotaxime and azithromycin was low and observed in 6.2 % (151/2486) and 0.9 % (16/1834) of the isolates, respectively. Several multi-drug resistant NTS lineages were resistant to 3GC due to different genetic mechanisms including bla CMY-2, bla CTX-M-55 or bla CTX-M-65. This study shows WGS can enhance existing AMR surveillance in NTS datasets routinely produced in public health laboratories to identify emerging AMR in NTS. These approaches will be critical for developing capacity to detect emerging public health threats such as resistance to 3GC.
- Published
- 2021
20. COVID-19: Integrating genomic and epidemiological data to inform public health interventions and policy in Tasmania, Australia
- Author
-
Stephens, N, McPherson, M, Cooley, L, Vanhaeften, R, Wilmot, M, Lane, C, Harlock, M, Lodo, K, Castree, N, Seemann, T, Sait, M, Ballard, S, Horan, K, Veitch, M, Johnston, F, Sherry, N, Howden, B, Stephens, N, McPherson, M, Cooley, L, Vanhaeften, R, Wilmot, M, Lane, C, Harlock, M, Lodo, K, Castree, N, Seemann, T, Sait, M, Ballard, S, Horan, K, Veitch, M, Johnston, F, Sherry, N, and Howden, B
- Abstract
OBJECTIVE: We undertook an integrated analysis of genomic and epidemiological data to investigate a large health-care-associated outbreak of coronavirus disease 2019 (COVID-19) and to better understand the epidemiology of COVID-19 cases in Tasmania, Australia. METHODS: Epidemiological data collected on COVID-19 cases notified in Tasmania between 2 March and 15 May 2020, and positive samples of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or RNA extracted from the samples were included. Sequencing was conducted by tiled amplicon polymerase chain reaction with ARTIC v1 or v3 primers and Illumina sequencing. Consensus sequences were generated, sequences were aligned to a reference sequence and phylogenetic analysis was performed. Genomic clusters were determined and integrated with epidemiological data to provide additional information. RESULTS: All 231 COVID-19 cases notified in Tasmania during the study period and 266 SARS-CoV-2-positive samples, representing 217/231 (94%) notified cases, were included; 184/217 (84%) were clustered, 21/217 (10%) were unique and 12/217 (6%) could not be sequenced. Genomics confirmed the presence of seven clusters already identified through epidemiological links, clarified transmission networks in which the epidemiology had been unclear and identified one cluster that had not previously been recognized. DISCUSSION: Genomic analysis provided useful additional information on COVID-19 in Tasmania, including evidence of a large health-care-associated outbreak linked to an overseas cruise, the probable source of infection in cases with no previously identified epidemiological link and confirmation that there was no identified community transmission from other imported cases. Genomic insights are an important component of the response to COVID-19, and continuing genomic surveillance is warranted.
- Published
- 2021
21. Second SARS-CoV-2 infections twelve months after initial infections in Australia, confirmed by genomic analysis
- Author
-
Minko, C, Haile, F, Gu, J, Kidd, D, Cross, M, Baptista, M, Crouch, S, Pierce, AB, Stuart, RL, Lane, CR, Johnson, S, Sherry, NL, Sait, M, Horan, K, Ballard, SA, Wilmot, M, Watt, A, Crachi, C, Seemann, T, Howden, BP, Minko, C, Haile, F, Gu, J, Kidd, D, Cross, M, Baptista, M, Crouch, S, Pierce, AB, Stuart, RL, Lane, CR, Johnson, S, Sherry, NL, Sait, M, Horan, K, Ballard, SA, Wilmot, M, Watt, A, Crachi, C, Seemann, T, and Howden, BP
- Published
- 2021
22. Viral Genomics to Inform Infection-control Response in Occupational Coronavirus Disease 2019 (COVID-19) Transmission
- Author
-
Whyler, NCA, Sherry, NL, Lane, CR, Seemann, T, Andersson, P, Sait, M, Graham, M, Korman, TM, Howden, BP, Stuart, RL, Whyler, NCA, Sherry, NL, Lane, CR, Seemann, T, Andersson, P, Sait, M, Graham, M, Korman, TM, Howden, BP, and Stuart, RL
- Abstract
Healthcare workers are at increased risk of occupational transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report 2 instances of healthcare workers contracting SARS-CoV-2 despite no known breach of personal protective equipment. Additional specific equipment cleaning was initiated. Viral genomic sequencing supported this transmission hypothesis and our subsequent response.
- Published
- 2021
23. Genomic Epidemiology and Antimicrobial Resistance Mechanisms of Imported Typhoid in Australia
- Author
-
Ingle, DJ, Andersson, P, Valcanis, M, Wilmot, M, Easton, M, Lane, C, Barden, J, da Silva, AG, Seemann, T, Horan, K, Ballard, SA, Sherry, NL, Williamson, DA, Howden, BP, Ingle, DJ, Andersson, P, Valcanis, M, Wilmot, M, Easton, M, Lane, C, Barden, J, da Silva, AG, Seemann, T, Horan, K, Ballard, SA, Sherry, NL, Williamson, DA, and Howden, BP
- Abstract
Typhoid fever is an invasive bacterial disease of humans that disproportionately affects low- and middle-income countries. Antimicrobial resistance (AMR) has been increasingly prevalent in recent decades in Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, limiting treatment options. In Australia, most cases of typhoid fever are imported due to travel to regions where typhoid fever is endemic. Here, all 116 isolates of S. Typhi isolated in Victoria, Australia, between 1 July 2018 and 30 June 2020, underwent whole-genome sequencing and antimicrobial susceptibility testing. Genomic data were linked to international travel data collected from routine case interviews. Travel to South Asia accounted for most cases, with 92.2% imported from seven primary countries (the top two were India, n = 87, and Pakistan, n = 12). A total of 17 S. Typhi genotypes were detected in the 2-year cohort, with 48.2% genotyped as part of global AMR lineages. Ciprofloxacin resistance was detected in two lineages, 3.3 and 4.3.1.2, all from cases with reported travel to India. Nearly all multidrug and extensively drug resistant isolates (90%) were from cases with reported travel to Pakistan in genotypes 4.3.1.1 and 4.3.1.1.P1. Extended spectrum beta-lactamases, blaCTX-M-15 and blaSHV-12, were detected in cases with travel to Pakistan and India, respectively. Linking epidemiological data with genomic studies of S. Typhi provides an opportunity to improve understanding of the emergence, spread and risk of drug-resistant S. Typhi infections and to better inform empirical treatment guidelines in returned travelers.
- Published
- 2021
24. Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study
- Author
-
Lane, CR, Sherry, NL, Porter, AF, Duchene, S, Horan, K, Andersson, P, Wilmot, M, Turner, A, Dougall, S, Johnson, SA, Sait, M, da Silva, AG, Ballard, SA, Hoang, T, Stinear, TP, Caly, L, Sintchenko, V, Graham, R, McMahon, J, Smith, D, Leong, LEX, Meumann, EM, Cooley, L, Schwessinger, B, Rawlinson, W, van Hal, SJ, Stephens, N, Catton, M, Looker, C, Crouch, S, Sutton, B, Alpren, C, Williamson, DA, Seemann, T, Howden, BP, Lane, CR, Sherry, NL, Porter, AF, Duchene, S, Horan, K, Andersson, P, Wilmot, M, Turner, A, Dougall, S, Johnson, SA, Sait, M, da Silva, AG, Ballard, SA, Hoang, T, Stinear, TP, Caly, L, Sintchenko, V, Graham, R, McMahon, J, Smith, D, Leong, LEX, Meumann, EM, Cooley, L, Schwessinger, B, Rawlinson, W, van Hal, SJ, Stephens, N, Catton, M, Looker, C, Crouch, S, Sutton, B, Alpren, C, Williamson, DA, Seemann, T, and Howden, BP
- Abstract
BACKGROUND: A cornerstone of Australia's ability to control COVID-19 has been effective border control with an extensive supervised quarantine programme. However, a rapid recrudescence of COVID-19 was observed in the state of Victoria in June, 2020. We aim to describe the genomic findings that located the source of this second wave and show the role of genomic epidemiology in the successful elimination of COVID-19 for a second time in Australia. METHODS: In this observational, genomic epidemiological study, we did genomic sequencing of all laboratory-confirmed cases of COVID-19 diagnosed in Victoria, Australia between Jan 25, 2020, and Jan 31, 2021. We did phylogenetic analyses, genomic cluster discovery, and integrated results with epidemiological data (detailed information on demographics, risk factors, and exposure) collected via interview by the Victorian Government Department of Health. Genomic transmission networks were used to group multiple genomic clusters when epidemiological and genomic data suggested they arose from a single importation event and diversified within Victoria. To identify transmission of emergent lineages between Victoria and other states or territories in Australia, all publicly available SARS-CoV-2 sequences uploaded before Feb 11, 2021, were obtained from the national sequence sharing programme AusTrakka, and epidemiological data were obtained from the submitting laboratories. We did phylodynamic analyses to estimate the growth rate, doubling time, and number of days from the first local infection to the collection of the first sequenced genome for the dominant local cluster, and compared our growth estimates to previously published estimates from a similar growth phase of lineage B.1.1.7 (also known as the Alpha variant) in the UK. FINDINGS: Between Jan 25, 2020, and Jan 31, 2021, there were 20 451 laboratory-confirmed cases of COVID-19 in Victoria, Australia, of which 15 431 were submitted for sequencing, and 11 711 met all quality co
- Published
- 2021
25. Search and Contain: Impact of an Integrated Genomic and Epidemiological Surveillance and Response Program for Control of Carbapenemase-producing Enterobacterales
- Author
-
Lane, CR, Brett, J, Schultz, M, Gorrie, CL, Stevens, K, Cameron, DRM, St George, S, van Diemen, A, Easton, M, Stuart, RL, Sait, M, Peleg, AY, Stewardson, AJ, Cheng, AC, Spelman, DW, Waters, MJ, Ballard, SA, Sherry, NL, Williamson, DA, Romanes, F, Sutton, B, Kwong, JC, Seemann, T, da Silva, AG, Stephens, N, Howden, BP, Lane, CR, Brett, J, Schultz, M, Gorrie, CL, Stevens, K, Cameron, DRM, St George, S, van Diemen, A, Easton, M, Stuart, RL, Sait, M, Peleg, AY, Stewardson, AJ, Cheng, AC, Spelman, DW, Waters, MJ, Ballard, SA, Sherry, NL, Williamson, DA, Romanes, F, Sutton, B, Kwong, JC, Seemann, T, da Silva, AG, Stephens, N, and Howden, BP
- Abstract
BACKGROUND: Multiresistant organisms (MROs) pose a critical threat to public health. Population-based programs for control of MROs such as carbapenemase-producing Enterobacterales (CPE) have emerged and evaluation is needed. We assessed the feasibility and impact of a statewide CPE surveillance and response program deployed across Victoria, Australia (population 6.5 million). METHODS: A prospective multimodal intervention including active screening, carrier isolation, centralized case investigation, and comparative pathogen genomics was implemented. We analyzed trends in CPE incidence and clinical presentation, risk factors, and local transmission over the program's first 3 years (2016-2018). RESULTS: CPE case ascertainment increased over the study period to 1.42 cases/100 000 population, linked to increased screening without a concomitant rise in active clinical infections (0.45-0.60 infections/100 000 population, P = .640). KPC-2 infection decreased from 0.29 infections/100 000 population prior to intervention to 0.03 infections/100 000 population in 2018 (P = .003). Comprehensive case investigation identified instances of overseas community acquisition. Median time between isolate referral and genomic and epidemiological assessment for local transmission was 11 days (IQR, 9-14). Prospective surveillance identified numerous small transmission networks (median, 2; range, 1-19 cases), predominantly IMP and KPC, with median pairwise distance of 8 (IQR, 4-13) single nucleotide polymorphisms; low diversity between clusters of the same sequence type suggested genomic cluster definitions alone are insufficient for targeted response. CONCLUSIONS: We demonstrate the value of centralized CPE control programs to increase case ascertainment, resolve risk factors, and identify local transmission through prospective genomic and epidemiological surveillance; methodologies are transferable to low-prevalence settings and MROs globally.
- Published
- 2021
26. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch.
- Author
-
O'Toole, Á, Hill, V, Pybus, OG, Watts, A, Bogoch, II, Khan, K, Messina, JP, COVID-19 Genomics UK (COG-UK) consortium, Network for Genomic Surveillance in South Africa (NGS-SA), Brazil-UK CADDE Genomic Network, Tegally, H, Lessells, RR, Giandhari, J, Pillay, S, Tumedi, KA, Nyepetsi, G, Kebabonye, M, Matsheka, M, Mine, M, Tokajian, S, Hassan, H, Salloum, T, Merhi, G, Koweyes, J, Geoghegan, JL, de Ligt, J, Ren, X, Storey, M, Freed, NE, Pattabiraman, C, Prasad, P, Desai, AS, Vasanthapuram, R, Schulz, TF, Steinbrück, L, Stadler, T, Swiss Viollier Sequencing Consortium, Parisi, A, Bianco, A, García de Viedma, D, Buenestado-Serrano, S, Borges, V, Isidro, J, Duarte, S, Gomes, JP, Zuckerman, NS, Mandelboim, M, Mor, O, Seemann, T, Arnott, A, Draper, J, Gall, M, Rawlinson, W, Deveson, I, Schlebusch, S, McMahon, J, Leong, L, Lim, CK, Chironna, M, Loconsole, D, Bal, A, Josset, L, Holmes, E, St George, K, Lasek-Nesselquist, E, Sikkema, RS, Oude Munnink, B, Koopmans, M, Brytting, M, Sudha Rani, V, Pavani, S, Smura, T, Heim, A, Kurkela, S, Umair, M, Salman, M, Bartolini, B, Rueca, M, Drosten, C, Wolff, T, Silander, O, Eggink, D, Reusken, C, Vennema, H, Park, A, Carrington, C, Sahadeo, N, Carr, M, Gonzalez, G, SEARCH Alliance San Diego, National Virus Reference Laboratory, SeqCOVID-Spain, Danish Covid-19 Genome Consortium (DCGC), Communicable Diseases Genomic Network (CDGN), Dutch National SARS-CoV-2 surveillance program, Division of Emerging Infectious Diseases (KDCA), de Oliveira, T, Faria, N, Rambaut, A, Kraemer, MUG, O'Toole, Á, Hill, V, Pybus, OG, Watts, A, Bogoch, II, Khan, K, Messina, JP, COVID-19 Genomics UK (COG-UK) consortium, Network for Genomic Surveillance in South Africa (NGS-SA), Brazil-UK CADDE Genomic Network, Tegally, H, Lessells, RR, Giandhari, J, Pillay, S, Tumedi, KA, Nyepetsi, G, Kebabonye, M, Matsheka, M, Mine, M, Tokajian, S, Hassan, H, Salloum, T, Merhi, G, Koweyes, J, Geoghegan, JL, de Ligt, J, Ren, X, Storey, M, Freed, NE, Pattabiraman, C, Prasad, P, Desai, AS, Vasanthapuram, R, Schulz, TF, Steinbrück, L, Stadler, T, Swiss Viollier Sequencing Consortium, Parisi, A, Bianco, A, García de Viedma, D, Buenestado-Serrano, S, Borges, V, Isidro, J, Duarte, S, Gomes, JP, Zuckerman, NS, Mandelboim, M, Mor, O, Seemann, T, Arnott, A, Draper, J, Gall, M, Rawlinson, W, Deveson, I, Schlebusch, S, McMahon, J, Leong, L, Lim, CK, Chironna, M, Loconsole, D, Bal, A, Josset, L, Holmes, E, St George, K, Lasek-Nesselquist, E, Sikkema, RS, Oude Munnink, B, Koopmans, M, Brytting, M, Sudha Rani, V, Pavani, S, Smura, T, Heim, A, Kurkela, S, Umair, M, Salman, M, Bartolini, B, Rueca, M, Drosten, C, Wolff, T, Silander, O, Eggink, D, Reusken, C, Vennema, H, Park, A, Carrington, C, Sahadeo, N, Carr, M, Gonzalez, G, SEARCH Alliance San Diego, National Virus Reference Laboratory, SeqCOVID-Spain, Danish Covid-19 Genome Consortium (DCGC), Communicable Diseases Genomic Network (CDGN), Dutch National SARS-CoV-2 surveillance program, Division of Emerging Infectious Diseases (KDCA), de Oliveira, T, Faria, N, Rambaut, A, and Kraemer, MUG
- Abstract
Late in 2020, two genetically-distinct clusters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with mutations of biological concern were reported, one in the United Kingdom and one in South Africa. Using a combination of data from routine surveillance, genomic sequencing and international travel we track the international dispersal of lineages B.1.1.7 and B.1.351 (variant 501Y-V2). We account for potential biases in genomic surveillance efforts by including passenger volumes from location of where the lineage was first reported, London and South Africa respectively. Using the software tool grinch (global report investigating novel coronavirus haplotypes), we track the international spread of lineages of concern with automated daily reports, Further, we have built a custom tracking website (cov-lineages.org/global_report.html) which hosts this daily report and will continue to include novel SARS-CoV-2 lineages of concern as they are detected.
- Published
- 2021
27. Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral Replication
- Author
-
Gordon, CL, Smibert, OC, Holmes, NE, Chua, KYL, Rose, M, Drewett, G, James, F, Mouhtouris, E, Nguyen, THO, Zhang, W, Kedzierski, L, Rowntree, LC, Chua, BY, Caly, L, Catton, MG, Druce, J, Sait, M, Seemann, T, Sherry, NL, Howden, BP, Kedzierska, K, Kwong, JC, Trubiano, JA, Gordon, CL, Smibert, OC, Holmes, NE, Chua, KYL, Rose, M, Drewett, G, James, F, Mouhtouris, E, Nguyen, THO, Zhang, W, Kedzierski, L, Rowntree, LC, Chua, BY, Caly, L, Catton, MG, Druce, J, Sait, M, Seemann, T, Sherry, NL, Howden, BP, Kedzierska, K, Kwong, JC, and Trubiano, JA
- Abstract
We describe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune responses in a patient with lymphoma and recent programmed death 1 (PD-1) inhibitor therapy with late onset of severe coronavirus disease 2019 disease and prolonged SARS-CoV-2 replication, in comparison to age-matched and immunocompromised controls. High levels of HLA-DR+/CD38+ activation, interleukin 6, and interleukin 18 in the absence of B cells and PD-1 expression was observed. SARS-CoV-2-specific antibody responses were absent and SARS-CoV-2-specific T cells were minimally detected. This case highlights challenges in managing immunocompromised hosts who may fail to mount effective virus-specific immune responses.
- Published
- 2021
28. Daptomycin Resistance Occurs Predominantly in vanA-Type Vancomycin-Resistant Enterococcus faecium in Australasia and Is Associated With Heterogeneous and Novel Mutations
- Author
-
Li, L, Higgs, C, Turner, AM, Nong, Y, Gorrie, CL, Sherry, NL, Dyet, KH, Seemann, T, Williamson, DA, Stinear, TP, Howden, BP, Carter, GP, Li, L, Higgs, C, Turner, AM, Nong, Y, Gorrie, CL, Sherry, NL, Dyet, KH, Seemann, T, Williamson, DA, Stinear, TP, Howden, BP, and Carter, GP
- Abstract
Healthcare associated infections caused by vancomycin-resistant Enterococcus faecium (VREfm) have a major impact on health outcomes. VREfm is difficult to treat because of intrinsic and acquired resistance to many clinically used antimicrobials, with daptomycin being one of the few last line therapeutic options for treating multidrug-resistant VREfm. The emergence of daptomycin-resistant VREfm is therefore of serious clinical concern. Despite this, the impact that daptomycin-resistant VREfm have on patient health outcomes is not clearly defined and knowledge on the mechanisms and genetic signatures linked with daptomycin resistance in VREfm remains incomplete. To address these knowledge gaps, phenotypic daptomycin susceptibility testing was undertaken on 324 E. faecium isolates from Australia and New Zealand. Approximately 15% of study isolates were phenotypically resistant to daptomycin. Whole genome sequencing revealed a strong association between vanA-VREfm and daptomycin resistance, with 95% of daptomycin-resistant study isolates harbouring vanA. Genomic analyses showed that daptomycin-resistant VREfm isolates were polyclonal and carried several previously characterised mutations in the liaR and liaS genes as well as several novel mutations within the rpoB, rpoC, and dltC genes. Overall, 70% of daptomycin-resistant study isolates were found to carry mutations within the liaR, rpoB, rpoC, or dltC genes. Finally, in a mouse model of VREfm bacteraemia, infection with the locally dominant daptomycin-resistant clone led to reduced daptomycin treatment efficacy in comparison to daptomycin-susceptible E. faecium. These findings have important implications for ongoing VREfm surveillance activities and the treatment of VREfm infections.
- Published
- 2021
29. Accessible Platform for High-Throughput COVID-19 Molecular Diagnostics and Genome Sequencing Using a Repurposed 3D Printer for RNA Extraction
- Author
-
Vandelannoote, K, Buultjens, AH, Li, L, Sharkey, LK, Herisse, M, Pidot, SJ, Tuyet, H, Howden, BP, Monk, IR, Seemann, T, Lee, JYH, Stinear, TP, Vandelannoote, K, Buultjens, AH, Li, L, Sharkey, LK, Herisse, M, Pidot, SJ, Tuyet, H, Howden, BP, Monk, IR, Seemann, T, Lee, JYH, and Stinear, TP
- Abstract
The COVID-19 pandemic has exposed the dependence of diagnostic laboratories on a handful of large corporations with market monopolies on the worldwide supply of reagents, consumables, and hardware for molecular diagnostics. Global shortages of key consumables for RT-qPCR detection of SARS-CoV-2 RNA have impaired the ability to run essential, routine diagnostic services. Here, we describe a workflow for rapid detection of SARS-CoV-2 RNA in upper respiratory samples including nasal swabs and saliva, utilizing low-cost equipment and readily accessible reagents. Using repurposed Creality3D Ender-3 three-dimensional (3D) printers, we built a semiautomated paramagnetic bead RNA extraction platform. The hardware for the system was built for $300 USD, and the material cost per reaction was $1 USD. Named the Ender VX500, instrument performance when paired with RT-qPCR for SARS-CoV-2 detection in nasal and saliva specimens was two virus copies per microliter. There was a high-performance agreement (assessed using 458 COVID-19 nasal swab specimens) with the Aptima SARS-CoV-2 assay run on the Hologic Panther, a commercial automated RNA extraction and detection platform. Inter- and intrainstrument precision was excellent (coefficients of variation (CoV) of 1.10 and 0.66-1.32%, respectively) across four instruments. The platform is scalable with throughput ranging from 23 specimens on a single instrument run by one user in 50 min to 364 specimens on four instruments run by four users in 190 min. Step-by-step instructions and protocols for building and running the Ender VX500 have been made available without restriction.
- Published
- 2021
30. Tuberculosis in Australia's tropical north: a population-based genomic epidemiological study
- Author
-
Meumann, EM, Horan, K, Ralph, AP, Farmer, B, Globan, M, Stephenson, E, Popple, T, Boyd, R, Kaestli, M, Seemann, T, Vandelannoote, K, Lowbridge, C, Baird, RW, Stinear, TP, Williamson, DA, Currie, BJ, Krause, VL, Meumann, EM, Horan, K, Ralph, AP, Farmer, B, Globan, M, Stephenson, E, Popple, T, Boyd, R, Kaestli, M, Seemann, T, Vandelannoote, K, Lowbridge, C, Baird, RW, Stinear, TP, Williamson, DA, Currie, BJ, and Krause, VL
- Abstract
BACKGROUND: The Northern Territory (NT) has the highest tuberculosis (TB) rate of all Australian jurisdictions. We combined TB public health surveillance data with genomic sequencing of Mycobacterium tuberculosis isolates in the tropical 'Top End' of the NT to investigate trends in TB incidence and transmission. METHODS: This retrospective observational study included all 741 culture-confirmed cases of TB in the Top End over three decades from 1989-2020. All 497 available M. tuberculosis isolates were sequenced. We used contact tracing data to define a threshold pairwise SNP distance for hierarchical single linkage clustering, and examined putative transmission clusters in the context of epidemiologic information. FINDINGS: There were 359 (48%) cases born overseas, 329 (44%) cases among Australian First Nations peoples, and 52 (7%) cases were Australian-born and non-Indigenous. The annual incidence in First Nations peoples from 1989-2019 fell from average 50.4 to 11.0 per 100,000 (P<0·001). First Nations cases were more likely to die from TB (41/329, 12·5%) than overseas-born cases (11/359, 3·1%; P<0·001). Using a threshold of ≤12 SNPs, 28 clusters of between 2-64 individuals were identified, totalling 250 cases; 214 (86%) were First Nations cases and 189 (76%) were from a remote region. The time between cases and past epidemiologically- and genomically-linked contacts ranged from 4·5 months to 24 years. INTERPRETATION: Our findings support prioritisation of timely case detection, contact tracing augmented by genomic sequencing, and latent TB treatment to break transmission chains in Top End remote hotspot regions.
- Published
- 2021
31. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia.
- Author
-
Tran T., Kostecki R., Yoga Y., Naughton W., Taiaroa G., Seemann T., Schultz M.B., Howden B.P., Korman T.M., Lewin S.R., Williamson D.A., Catton M.G., Caly L., Druce J., Roberts J., Bond K., Tran T., Kostecki R., Yoga Y., Naughton W., Taiaroa G., Seemann T., Schultz M.B., Howden B.P., Korman T.M., Lewin S.R., Williamson D.A., Catton M.G., Caly L., Druce J., Roberts J., and Bond K.
- Abstract
Objectives: To describe the first isolation and sequencing of SARS-CoV-2 in Australia and rapid sharing of the isolate. Setting(s): SARS-CoV-2 was isolated from a 58-year-old man from Wuhan, China who arrived in Melbourne on 19 January 2020 and was admitted to the Monash Medical Centre, Melbourne from the emergency department on 24 January 2020 with fever, cough, and progressive dyspnoea. Major outcomes: Clinical course and laboratory features of the first reported case of COVID-19 (the illness caused by SARS-CoV-2) in Australia; isolation, whole genome sequencing, imaging, and rapid sharing of virus from the patient. Result(s): A nasopharyngeal swab and sputum collected when the patient presented to hospital were each positive for SARS-CoV-2 (reverse transcription polymerase chain reaction). Inoculation of Vero/hSLAM cells with material from the nasopharyngeal swab led to the isolation of SARS-CoV-2 virus in culture. Electron microscopy of the supernatant confirmed the presence of virus particles with morphology characteristic of viruses of the family Coronaviridae. Whole genome sequencing of the viral isolate and phylogenetic analysis indicated the isolate exhibited greater than 99.99% sequence identity with other publicly available SARS-CoV-2 genomes. Within 24 hours of isolation, the first Australian SARS-CoV-2 isolate was shared with local and overseas reference laboratories and major North American and European culture collections. Conclusion(s): The ability to rapidly identify, propagate, and internationally share our SARS-CoV-2 isolate is an important step in collaborative scientific efforts to deal effectively with this international public health emergency by developing better diagnostic procedures, vaccine candidates, and antiviral agents.Copyright © 2020 AMPCo Pty Ltd
- Published
- 2020
32. Search and Contain: Impact of an integrated genomic and epidemiological surveillance and response program for control of carbapenemase-producing Enterobacterales.
- Author
-
van Diemen A., Stuart R.L., Spelman D.W., Cheng A.C., Stewardson A.J., Peleg A.Y., Sait M., Lane C.R., Brett J., Schultz M., Gorrie C.L., Stevens K., Cameron D.R.M., St George S., Easton M., Howden B.P., Stephens N., Goncalves da Silva A., Seemann T., Kwong J.C., Sutton B., Romanes F., Williamson D.A., Sherry N.L., Ballard S.A., Waters M.J., van Diemen A., Stuart R.L., Spelman D.W., Cheng A.C., Stewardson A.J., Peleg A.Y., Sait M., Lane C.R., Brett J., Schultz M., Gorrie C.L., Stevens K., Cameron D.R.M., St George S., Easton M., Howden B.P., Stephens N., Goncalves da Silva A., Seemann T., Kwong J.C., Sutton B., Romanes F., Williamson D.A., Sherry N.L., Ballard S.A., and Waters M.J.
- Abstract
BACKGROUND: Multi-resistant organisms (MROs) pose a critical threat to public health. Population-based programs for control of MROs such as Carbapenemase-producing Enterobacterales (CPE) have emerged and evaluation is needed. We assess the feasibility and impact of a state-wide CPE surveillance and response program deployed in December 2015 across Victoria, Australia (population 6.5 million). METHOD(S): A prospective multi-modal intervention including active screening, carrier isolation, centralised case investigation and comparative pathogen genomics was implemented. We analyze trend in CPE incidence and clinical presentation, risk factors and local transmission over the program's first three years (January 2016 to December 2018). RESULT(S): CPE case ascertainment increased over the study period to 1.42 cases/100,000 population, linked to increased screening without a concomitant rise in active clinical infections (0.45-0.60 infections/100,000 population, p=0.640). KPC-2 infection decreased from 0.29 infections/100,000 population prior to intervention to 0.03 infections/100,000 population in 2018 (p=0.003). Comprehensive case investigation identified putative overseas community acquisition. Median time between isolate referral and initial genomic and epidemiological assessment for local transmission was 11 days (IQR 9-14). Prospective surveillance identified numerous small transmission networks (median 2, range 1-19 cases), predominantly IMP and KPC, with median pairwise distance of 8 (IQR 4-13) single nucleotide polymorphisms; low diversity between clusters of the same sequence type suggested genomic cluster definitions alone are insufficient for targeted response. CONCLUSION(S): We demonstrate the value of centralised CPE control programs to increase case ascertainment, resolve risk factors and identify putative local transmission through prospective genomic and epidemiological surveillance; methodologies are transferable to low-prevalence settings and MROs globa
- Published
- 2020
33. Viral genomics to inform infection control response in occupational COVID-19 transmission.
- Author
-
Graham M., Andersson P., Sait M., Korman T.M., Stuart R.L., Howden B.P., Whyler N.C.A., Sherry N.L., Lane C.R., Seemann T., Graham M., Andersson P., Sait M., Korman T.M., Stuart R.L., Howden B.P., Whyler N.C.A., Sherry N.L., Lane C.R., and Seemann T.
- Abstract
Healthcare workers are at increased risk of occupational transmission of SARS-CoV-2. We report two instances of healthcare workers contracting SARS-CoV-2 despite no known breach of personal protective equipment. Additional specific equipment cleaning was initiated. Viral genomic sequencing supported this transmission hypothesis and our subsequent response.Copyright © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
- Published
- 2020
34. Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA.
- Author
-
Mercoulia K., Luttick A., McDonald S., Greenhalgh A., Kwong J.C., Sherry N.L., Graham M., Hoang T., Herisse M., Pidot S.J., Williamson D.A., Howden B.P., Monk I.R., Stinear T.P., Lee J.Y.H., Best N., McAuley J., Porter J.L., Seemann T., Schultz M.B., Sait M., Orlando N., Ballard S.A., Druce J., Tran T., Catton M.G., Pryor M.J., Cui H.L., Mercoulia K., Luttick A., McDonald S., Greenhalgh A., Kwong J.C., Sherry N.L., Graham M., Hoang T., Herisse M., Pidot S.J., Williamson D.A., Howden B.P., Monk I.R., Stinear T.P., Lee J.Y.H., Best N., McAuley J., Porter J.L., Seemann T., Schultz M.B., Sait M., Orlando N., Ballard S.A., Druce J., Tran T., Catton M.G., Pryor M.J., and Cui H.L.
- Abstract
Introduction. The SARS-CoV-2 pandemic of 2020 has resulted in unparalleled requirements for RNA extraction kits and enzymes required for virus detection, leading to global shortages. This has necessitated the exploration of alternative diagnostic options to alleviate supply chain issues. Aim. To establish and validate a reverse transcription loop-mediated isothermal amplification (RT- LAMP) assay for the detection of SARS-CoV-2 from nasopharyngeal swabs. Methodology. We used a commercial RT-LAMP mastermix from OptiGene in combination with a primer set designed to detect the CDC N1 region of the SARS-CoV-2 nucleocapsid (N) gene. A single-tube, single-step fluorescence assay was implemented whereby 1 microl of universal transport medium (UTM) directly from a nasopharyngeal swab could be used as template, bypassing the requirement for RNA purification. Amplification and detection could be conducted in any thermocycler capable of holding 65 degreeC for 30 min and measure fluorescence in the FAM channel at 1 min intervals. Results. Assay evaluation by assessment of 157 clinical specimens previously screened by E-gene RT-qPCR revealed assay sensitivity and specificity of 87 and 100%, respectively. Results were fast, with an average time-to-positive (Tp) for 93 clinical samples of 14 min (sd+/-7 min). Using dilutions of SARS-CoV-2 virus spiked into UTM, we also evaluated assay performance against FDA guidelines for implementation of emergency-use diagnostics and established a limit-of-detection of 54 Tissue Culture Infectious Dose 50 per ml (TCID50 ml-1), with satisfactory assay sensitivity and specificity. A comparison of 20 clinical specimens between four laboratories showed excellent interlaboratory concordance; performing equally well on three different, commonly used thermocyclers, pointing to the robustness of the assay. Conclusion. With a simplified workflow, The N1 gene Single Tube Optigene LAMP assay (N1-STOP-LAMP) is a powerful, scalable option for specific and r
- Published
- 2020
35. Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA
- Author
-
Lee, JYH, Best, N, McAuley, J, Porter, JL, Seemann, T, Schultz, MB, Sait, M, Orlando, N, Mercoulia, K, Ballard, SA, Druce, J, Tran, T, Catton, MG, Pryor, MJ, Cui, HL, Luttick, A, McDonald, S, Greenhalgh, A, Kwong, JC, Sherry, NL, Graham, M, Hoang, T, Herisse, M, Pidot, SJ, Williamson, DA, Howden, BP, Monk, IR, Stinear, TP, Lee, JYH, Best, N, McAuley, J, Porter, JL, Seemann, T, Schultz, MB, Sait, M, Orlando, N, Mercoulia, K, Ballard, SA, Druce, J, Tran, T, Catton, MG, Pryor, MJ, Cui, HL, Luttick, A, McDonald, S, Greenhalgh, A, Kwong, JC, Sherry, NL, Graham, M, Hoang, T, Herisse, M, Pidot, SJ, Williamson, DA, Howden, BP, Monk, IR, and Stinear, TP
- Abstract
Introduction. The SARS-CoV-2 pandemic of 2020 has resulted in unparalleled requirements for RNA extraction kits and enzymes required for virus detection, leading to global shortages. This has necessitated the exploration of alternative diagnostic options to alleviate supply chain issues.Aim. To establish and validate a reverse transcription loop-mediated isothermal amplification (RT- LAMP) assay for the detection of SARS-CoV-2 from nasopharyngeal swabs.Methodology. We used a commercial RT-LAMP mastermix from OptiGene in combination with a primer set designed to detect the CDC N1 region of the SARS-CoV-2 nucleocapsid (N) gene. A single-tube, single-step fluorescence assay was implemented whereby 1 µl of universal transport medium (UTM) directly from a nasopharyngeal swab could be used as template, bypassing the requirement for RNA purification. Amplification and detection could be conducted in any thermocycler capable of holding 65 °C for 30 min and measure fluorescence in the FAM channel at 1 min intervals.Results. Assay evaluation by assessment of 157 clinical specimens previously screened by E-gene RT-qPCR revealed assay sensitivity and specificity of 87 and 100%, respectively. Results were fast, with an average time-to-positive (Tp) for 93 clinical samples of 14 min (sd±7 min). Using dilutions of SARS-CoV-2 virus spiked into UTM, we also evaluated assay performance against FDA guidelines for implementation of emergency-use diagnostics and established a limit-of-detection of 54 Tissue Culture Infectious Dose 50 per ml (TCID50 ml-1), with satisfactory assay sensitivity and specificity. A comparison of 20 clinical specimens between four laboratories showed excellent interlaboratory concordance; performing equally well on three different, commonly used thermocyclers, pointing to the robustness of the assay.Conclusion. With a simplified workflow, The N1 gene Single Tube Optigene LAMP assay (N1-STOP-LAMP) is a powerful, scalable option for specific and rapid detection
- Published
- 2020
36. Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia
- Author
-
Caly, L, Druce, J, Roberts, J, Bond, K, Tran, T, Kostecki, R, Yoga, Y, Naughton, W, Taiaroa, G, Seemann, T, Schultz, MB, Howden, BP, Korman, TM, Lewin, SR, Williamson, DA, Catton, MG, Caly, L, Druce, J, Roberts, J, Bond, K, Tran, T, Kostecki, R, Yoga, Y, Naughton, W, Taiaroa, G, Seemann, T, Schultz, MB, Howden, BP, Korman, TM, Lewin, SR, Williamson, DA, and Catton, MG
- Abstract
OBJECTIVES: To describe the first isolation and sequencing of SARS-CoV-2 in Australia and rapid sharing of the isolate. SETTING: SARS-CoV-2 was isolated from a 58-year-old man from Wuhan, China who arrived in Melbourne on 19 January 2020 and was admitted to the Monash Medical Centre, Melbourne from the emergency department on 24 January 2020 with fever, cough, and progressive dyspnoea. MAJOR OUTCOMES: Clinical course and laboratory features of the first reported case of COVID-19 (the illness caused by SARS-CoV-2) in Australia; isolation, whole genome sequencing, imaging, and rapid sharing of virus from the patient. RESULTS: A nasopharyngeal swab and sputum collected when the patient presented to hospital were each positive for SARS-CoV-2 (reverse transcription polymerase chain reaction). Inoculation of Vero/hSLAM cells with material from the nasopharyngeal swab led to the isolation of SARS-CoV-2 virus in culture. Electron microscopy of the supernatant confirmed the presence of virus particles with morphology characteristic of viruses of the family Coronaviridae. Whole genome sequencing of the viral isolate and phylogenetic analysis indicated the isolate exhibited greater than 99.99% sequence identity with other publicly available SARS-CoV-2 genomes. Within 24 hours of isolation, the first Australian SARS-CoV-2 isolate was shared with local and overseas reference laboratories and major North American and European culture collections. CONCLUSIONS: The ability to rapidly identify, propagate, and internationally share our SARS-CoV-2 isolate is an important step in collaborative scientific efforts to deal effectively with this international public health emergency by developing better diagnostic procedures, vaccine candidates, and antiviral agents.
- Published
- 2020
37. Complete microbial genomes for public health in Australia and the Southwest Pacific
- Author
-
Baines, SL, da Silva, AG, Carter, GP, Jennison, A, Rathnayake, I, Graham, RM, Sintchenko, V, Wang, Q, Rockett, RJ, Timms, VJ, Martinez, E, Ballard, S, Tomita, T, Isles, N, Horan, KA, Pitchers, W, Stinear, TP, Williamson, DA, Howden, BP, Seemann, T, Baines, SL, da Silva, AG, Carter, GP, Jennison, A, Rathnayake, I, Graham, RM, Sintchenko, V, Wang, Q, Rockett, RJ, Timms, VJ, Martinez, E, Ballard, S, Tomita, T, Isles, N, Horan, KA, Pitchers, W, Stinear, TP, Williamson, DA, Howden, BP, and Seemann, T
- Abstract
Complete genomes of microbial pathogens are essential for the phylogenomic analyses that increasingly underpin core public health laboratory activities. Here, we announce a BioProject (PRJNA556438) dedicated to sharing complete genomes chosen to represent a range of pathogenic bacteria with regional importance to Australia and the Southwest Pacific; enriching the catalogue of globally available complete genomes for public health while providing valuable strains to regional public health microbiology laboratories. In this first step, we present 26 complete high-quality bacterial genomes. Additionally, we describe here a framework for reconstructing complete microbial genomes and highlight some of the challenges and considerations for accurate and reproducible genome reconstruction.
- Published
- 2020
38. Tracking the COVID-19 pandemic in Australia using genomics
- Author
-
Seemann, T, Lane, C, Sherry, N, Duchene, S, Goncalves da Silva, A, Caly, L, Sait, M, Ballard, S, Horan, K, Schultz, M, Hoang, T, Easton, M, Dougall, S, Stinear, T, Druce, J, Catton, M, Sutton, B, van Diemen, A, Alpren, C, Williamson, D, Howden, B, Seemann, T, Lane, C, Sherry, N, Duchene, S, Goncalves da Silva, A, Caly, L, Sait, M, Ballard, S, Horan, K, Schultz, M, Hoang, T, Easton, M, Dougall, S, Stinear, T, Druce, J, Catton, M, Sutton, B, van Diemen, A, Alpren, C, Williamson, D, and Howden, B
- Abstract
BACKGROUND: Whole-genome sequencing of pathogens can improve resolution of outbreak clusters and define possible transmission networks. We applied high-throughput genome sequencing of SARS-CoV-2 to 75% of cases in the State of Victoria (population 6.24 million) in Australia. METHODS: Cases of SARS-CoV-2 infection were detected through active case finding and contact tracing. A dedicated SARS-CoV-2 multidisciplinary genomic response team was formed to enable rapid integration of epidemiological and genomic data. Phylodynamic analysis was performed to assess the putative impact of social restrictions. RESULTS: Between 25 January and 14 April 2020, 1,333 COVID-19 cases were reported in Victoria, with a peak in late March. After applying internal quality control parameters, 903 samples were included in genomic analyses. Sequenced samples from Australia were representative of the global diversity of SARS-CoV-2, consistent with epidemiological findings of multiple importations and limited onward transmission. In total, 76 distinct genomic clusters were identified; these included large clusters associated with social venues, healthcare facilities and cruise ships. Sequencing of sequential samples from 98 patients revealed minimal intra-patient SARS-CoV-2 genomic diversity. Phylodynamic modelling indicated a significant reduction in the effective viral reproductive number (Re) from 1.63 to 0.48 after the implementation of travel restrictions and population-level physical distancing. CONCLUSIONS: Our data provide a comprehensive framework for the use of SARS-CoV-2 genomics in public health responses. The application of genomics to rapidly identify SARS-CoV-2 transmission chains will become critically important as social restrictions ease globally. Public health responses to emergent cases must be swift, highly focused and effective.
- Published
- 2020
39. Prolonged Outbreak of Multidrug-Resistant Shigella sonnei Harboring bla(CTX-M-27) in Victoria, Australia
- Author
-
Ingle, DJ, Andersson, P, Valcanis, M, Barnden, J, da Silva, AG, Horan, KA, Seemann, T, Easton, M, Williamson, DA, Sherry, NL, Howden, BP, Ingle, DJ, Andersson, P, Valcanis, M, Barnden, J, da Silva, AG, Horan, KA, Seemann, T, Easton, M, Williamson, DA, Sherry, NL, and Howden, BP
- Abstract
In Australia, cases of shigellosis usually occur in returned travelers from regions of shigellosis endemicity or in men who have sex with men. Resistance to multiple antibiotics has significantly increased in Shigella sonnei isolates and represents a significant public health concern. We investigate an outbreak of multidrug-resistant S. sonnei in Victoria, Australia. We undertook whole-genome sequencing of 54 extended-spectrum-beta-lactamase (ESBL)-producing S. sonnei isolates received at the Microbiological Diagnostic Unit Public Health Laboratory between January 2019 and March 2020. The population structure and antimicrobial resistance profiles were identified by genomic analyses, with 73 previously characterized Australian S. sonnei isolates providing context. Epidemiological data, including age and sex of the shigellosis cases, were also collected. There was a significant increase in cases of ESBL S. sonnei from July 2019. Most of the ESBL S. sonnei isolates (65%) fell within a single cluster that was predominantly comprised of male cases that were characterized by the presence of the blaCTX-M-27 gene conferring resistance to extended-spectrum cephalosporins. These isolates were also multidrug resistant, including resistance to azithromycin and co-trimoxazole and reduced susceptibility to ciprofloxacin. Our data uncovered a prolonged clonal outbreak of ESBL S. sonnei infection that was likely first introduced by returned travelers and has subsequently been circulating locally in Australia. The emergence of a local outbreak of ESBL S. sonnei with a multidrug-resistant profile, including reduced susceptibility to ciprofloxacin, represents a significant public health threat.
- Published
- 2020
40. Incursions of Candida auris into Australia, 2018
- Author
-
Lane, CR, Seemann, T, Worth, LJ, Easton, M, Pitchers, W, Wong, J, Cameron, D, Azzato, F, Bartolo, R, Mateevici, C, Marshall, C, Slavin, MA, Howden, BP, Williamson, DA, Lane, CR, Seemann, T, Worth, LJ, Easton, M, Pitchers, W, Wong, J, Cameron, D, Azzato, F, Bartolo, R, Mateevici, C, Marshall, C, Slavin, MA, Howden, BP, and Williamson, DA
- Abstract
Candida auris is an emerging global healthcare-associated pathogen. During July-December 2018, four patients with C. auris were identified in Victoria, Australia, all with previous overseas hospitalization. Phylogenetic analysis revealed putative transmission between 2 patients and suspected overseas acquisition in the others. Vigilant screening of at-risk patients is required.
- Published
- 2020
41. Comprehensive Genomic Investigation of Adaptive Mutations Driving the Low-Level Oxacillin Resistance Phenotype in Staphylococcus aureus
- Author
-
Pettigrew, MM, Giulieri, SG, Guerillot, R, Kwong, JC, Monk, IR, Hayes, AS, Daniel, D, Baines, S, Sherry, NL, Holmes, NE, Ward, P, Gao, W, Seemann, T, Stinear, TP, Howden, BP, Pettigrew, MM, Giulieri, SG, Guerillot, R, Kwong, JC, Monk, IR, Hayes, AS, Daniel, D, Baines, S, Sherry, NL, Holmes, NE, Ward, P, Gao, W, Seemann, T, Stinear, TP, and Howden, BP
- Abstract
Antistaphylococcal penicillins such as oxacillin are the key antibiotics in the treatment of invasive methicillin-susceptible Staphylococcus aureus (MSSA) infections; however, mec gene-independent resistance adaptation can cause treatment failure. Despite its clinical relevance, the basis of this phenomenon remains poorly understood. Here, we investigated the genomic adaptation to oxacillin at an unprecedented scale using a large collection of 503 clinical mec-negative isolates and 30 in vitro-adapted isolates from independent oxacillin exposures. By combining comparative genomics, evolutionary convergence, and genome-wide association analysis, we found 21 genetic loci associated with low-level oxacillin resistance, underscoring the polygenic nature of this phenotype. Evidence of adaptation was particularly strong for the c-di-AMP signal transduction pathways (gdpP and dacA) and in the clpXP chaperone-protease complex. The role of mutations in gdpP in conferring low-level oxacillin resistance was confirmed by allele-swapping experiments. We found that resistance to oxacillin emerges at high frequency in vitro (median, 2.9 × 10-6; interquartile range [IQR], 1.9 × 10-6 to 3.9 × 10-6), which is consistent with a recurrent minimum inhibitory concentration (MIC) increase across the global phylogeny of clinical isolates. Nevertheless, adaptation in clinical isolates appears sporadically, with no stably adapted lineages, suggesting a high fitness cost of resistance, confirmed by growth assessment of mutants in rich media. Our data provide a broader understanding of the emergence and dynamics of oxacillin resistance adaptation in S. aureus and a framework for future surveillance of this clinically important phenomenon.IMPORTANCE The majority of Staphylococcus aureus strains causing human disease are methicillin-susceptible (MSSA) and can be treated with antistaphylococcal penicillins (such as oxacillin). While acquisition of the mec gene represents the main resistance mecha
- Published
- 2020
42. Systematic analysis of key parameters for genomics-based real-time detection and tracking of multidrug-resistant bacteria
- Author
-
Gorrie, C, Da Silva, AG, Ingle, D, Higgs, C, Seemann, T, Stinear, T, Williamson, D, Kwong, J, Grayson, L, Sherry, N, Howden, B, Gorrie, C, Da Silva, AG, Ingle, D, Higgs, C, Seemann, T, Stinear, T, Williamson, D, Kwong, J, Grayson, L, Sherry, N, and Howden, B
- Abstract
Background: Pairwise single nucleotide polymorphisms (SNPs) are a cornerstone for genomic approaches to multidrug-resistant organisms (MDROs) transmission inference in hospitals. However, the impact of key analysis parameters on these inferences has not been systematically analysed. Methods: We conducted a multi-hospital 15-month prospective study, sequencing 1537 MDRO genomes for comparison; methicillin-resistant Staphylococcus aureus , vancomycin-resistant Enterococcus faecium , and extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae . We systematically assessed the impact of sample and reference genome diversity, masking of prophage and regions of recombination, cumulative genome analysis compared to a three-month sliding-window, and the comparative effects each of these had when applying a SNP threshold for inferring likely transmission (≤15 SNPs for S. aureus , ≤25 for other species). Findings: Across the species, using a reference genome of the same sequence type provided a greater degree of pairwise SNP resolution, compared to species and outgroup-reference alignments that typically resulted in inflated SNP distances and the possibility of missed transmission events. Omitting prophage regions had minimal impacts, however, omitting recombination regions a highly variable effect, often inflating the number of closely related pairs. Estimating pairwise SNP distances was more consistent using a sliding-window than a cumulative approach. Interpretation: The use of a closely-related reference genome, without masking of prophage or recombination regions, and a sliding-window for isolate inclusion is best for accurate and consistent MDRO transmission inference. The increased stability and resolution provided by these approaches means SNP thresholds for putative transmission inference can be more reliably applied among diverse MDROs. Funding: This work was supported by the Melbourne Genomics Health Alliance (funded by the State Govern
- Published
- 2020
43. Comparative Transcriptomic and Functional Assessments o Linezolid-Responsive Small RNA Genes in Staphylococcus aureus
- Author
-
Lal, R, Gao, W, Guerillot, R, Lin, YH, Tree, J, Beaume, M, Francois, P, Monk, IR, Seemann, T, Schrenzel, J, Howden, BP, Stinear, TP, Lal, R, Gao, W, Guerillot, R, Lin, YH, Tree, J, Beaume, M, Francois, P, Monk, IR, Seemann, T, Schrenzel, J, Howden, BP, and Stinear, TP
- Abstract
Staphylococcus aureus contains a repertoire of at least 50 and possibly 500 small RNAs (sRNAs). The functions of most sRNAs are not understood, although some are known to respond to environmental changes, including the presence of antibiotics. Here, in an effort to better understand the roles of sRNAs in the context of antibiotic exposure, we took a clinical methicillin-resistant S. aureus (MRSA) isolate and separately deleted eight sRNAs that were significantly upregulated in response to the last-line antibiotic linezolid as revealed by transcriptome sequencing (RNA-seq) comparisons. We also deleted an additional 10 sRNAs that were either highly expressed or previously found to respond to antibiotic exposure. There were no significant changes for any of the 18 mutants in a variety of phenotypic screens, including MIC screens, growth competition assays in the presence of linezolid, biofilm formation, and resistance to whole-blood killing. These data suggest sRNA functional redundancy, because despite their high expression levels upon antibiotic exposure, individual sRNA genes do not affect readily observable bacterial phenotypes. The sRNA transcriptional changes we measured during antibiotic exposure might also reflect sRNA "indifference," that is, a general stress response not specifically related to sRNA function. These data underscore the need for sensitive assays and new approaches to try and decipher the functions of sRNA genes in S. aureus IMPORTANCE Bacterial small RNAs (sRNAs) are RNA molecules that can have important regulatory roles across gene expression networks. There is a growing understanding of the scope and potential breadth of impact of sRNAs on global gene expression patterns in Staphylococcus aureus, a major human pathogen. Here, transcriptome comparisons were used to examine the roles of sRNA genes with a potential role in the response of S. aureus to antibiotic exposure. Although no measurable impact on key bacterial phenotypes was observed aft
- Published
- 2020
44. Linking petrographical and petrophysical properties to transport characteristics: A case from Boom Clay and Eigenbilzen Sands
- Author
-
Jacops, E., primary, Swennen, R., additional, Janssens, N., additional, Seemann, T., additional, Amann-Hildenbrand, A., additional, Krooss, B.M., additional, Littke, R., additional, Maes, N., additional, and Bruggeman, C., additional
- Published
- 2020
- Full Text
- View/download PDF
45. A nonclonal outbreak of vancomycin-sensitive Enterococcus faecalis bacteremia in a neonatal intensive care unit.
- Author
-
Howden B.P., Taylor J.E., Kwong J.C., Seemann T., Coombs G.W., Stuart R.L., Kotsanas D., Tan K., Scott C., Baade B., Cheng M.H.L., Tan Z.V., Howden B.P., Taylor J.E., Kwong J.C., Seemann T., Coombs G.W., Stuart R.L., Kotsanas D., Tan K., Scott C., Baade B., Cheng M.H.L., and Tan Z.V.
- Abstract
Objective: To describe an outbreak of bacteremia caused by vancomycin-sensitive Enterococcus faecalis (VSEfe). Design(s): An investigation by retrospective case control and molecular typing by whole-genome sequencing (WGS). Setting(s): A tertiary-care neonatal unit in Melbourne, Australia. Method(s): Risk factors for 30 consecutive neonates with VSEfe bacteremia from June 2011 to December 2014 were analyzed using a case control study. Controls were neonates matched for gestational age, birth weight, and year of birth. Isolates were typed using WGS, and multilocus sequence typing (MLST) was determined. Result(s): Bacteremia for case patients occurred at a median time after delivery of 23.5 days (interquartile range, 14.9-35.8). Previous described risk factors for nosocomial bacteremia did not contribute to excess risk for VSEfe. WGS typing results designated 43% ST179 as well as 14 other sequence types, indicating a polyclonal outbreak. A multimodal intervention that included education, insertion checklists, guidelines on maintenance and access of central lines, adjustments to the late onset sepsis antibiotic treatment, and the introduction of diaper bags for disposal of soiled diapers after being handled inside the bed, led to termination of the outbreak. Conclusion(s): Typing using WGS identified this outbreak as predominately nonclonal and therefore not due to cross transmission. A multimodal approach was then sought to reduce the incidence of VSEfe bacteremia.Copyright © 2019 by The Society for Healthcare Epidemiology of America. All rights reserved.
- Published
- 2019
46. A nonclonal outbreak of vancomycin-sensitive Enterococcus faecalis bacteremia in a neonatal intensive care unit
- Author
-
Kotsanas, D., Tan, K., Scott, C., Baade, B., Cheng, M.H.L., Tan, Z.V., Taylor, J.E., Kwong, J.C., Seemann, T., Coombs, G.W., Howden, B.P., Stuart, R.L., Kotsanas, D., Tan, K., Scott, C., Baade, B., Cheng, M.H.L., Tan, Z.V., Taylor, J.E., Kwong, J.C., Seemann, T., Coombs, G.W., Howden, B.P., and Stuart, R.L.
- Abstract
Objective: To describe an outbreak of bacteremia caused by vancomycin-sensitive Enterococcus faecalis (VSEfe). Design: An investigation by retrospective case control and molecular typing by whole-genome sequencing (WGS). Setting: A tertiary-care neonatal unit in Melbourne, Australia. Methods: Risk factors for 30 consecutive neonates with VSEfe bacteremia from June 2011 to December 2014 were analyzed using a case control study. Controls were neonates matched for gestational age, birth weight, and year of birth. Isolates were typed using WGS, and multilocus sequence typing (MLST) was determined. Results: Bacteremia for case patients occurred at a median time after delivery of 23.5 days (interquartile range, 14.9–35.8). Previous described risk factors for nosocomial bacteremia did not contribute to excess risk for VSEfe. WGS typing results designated 43% ST179 as well as 14 other sequence types, indicating a polyclonal outbreak. A multimodal intervention that included education, insertion checklists, guidelines on maintenance and access of central lines, adjustments to the late onset sepsis antibiotic treatment, and the introduction of diaper bags for disposal of soiled diapers after being handled inside the bed, led to termination of the outbreak. Conclusions: Typing using WGS identified this outbreak as predominately nonclonal and therefore not due to cross transmission. A multimodal approach was then sought to reduce the incidence of VSEfe bacteremia.
- Published
- 2019
47. Bridging of Neisseria gonorrhoeae lineages across sexual networks in the HIV pre-exposure prophylaxis era
- Author
-
Williamson, DA, Chow, EPF, Gorrie, CL, Seemann, T, Ingle, DJ, Higgins, N, Easton, M, Taiaroa, G, Grad, YH, Kwong, JC, Fairley, CK, Chen, MY, Howden, BP, Williamson, DA, Chow, EPF, Gorrie, CL, Seemann, T, Ingle, DJ, Higgins, N, Easton, M, Taiaroa, G, Grad, YH, Kwong, JC, Fairley, CK, Chen, MY, and Howden, BP
- Abstract
Whole genome sequencing (WGS) has been used to investigate transmission of Neisseria gonorrhoeae, but to date, most studies have not combined genomic data with detailed information on sexual behaviour to define the extent of transmission across population risk groups (bridging). Here, through combined epidemiological and genomic analysis of 2,186N. gonorrhoeae isolates from Australia, we show widespread transmission of N. gonorrhoeae within and between population groups. We describe distinct transmission clusters associated with men who have sex with men (MSM) and heterosexuals, and men who have sex with men and women (MSMW) are identified as a possible bridging population between these groups. Further, the study identifies transmission of N. gonorrhoeae between HIV-positive and HIV-negative individuals receiving pre-exposure prophylaxis (PrEP). Our data highlight several groups that can be targeted for interventions aimed at improving gonorrhoea control, including returning travellers, sex workers, and PrEP users.
- Published
- 2019
48. Zinc-binding to the cytoplasmic PAS domain regulates the essential WalK histidine kinase of Staphylococcus aureus
- Author
-
Monk, IR, Shaikh, N, Begg, SL, Gajdiss, M, Sharkey, LKR, Lee, JYH, Pidot, SJ, Seemann, T, Kuiper, M, Winnen, B, Hvorup, R, Collins, BM, Bierbaum, G, Udagedara, SR, Morey, JR, Pulyani, N, Howden, BP, Maher, MJ, McDevitt, CA, King, GF, Stinear, TP, Monk, IR, Shaikh, N, Begg, SL, Gajdiss, M, Sharkey, LKR, Lee, JYH, Pidot, SJ, Seemann, T, Kuiper, M, Winnen, B, Hvorup, R, Collins, BM, Bierbaum, G, Udagedara, SR, Morey, JR, Pulyani, N, Howden, BP, Maher, MJ, McDevitt, CA, King, GF, and Stinear, TP
- Abstract
WalKR (YycFG) is the only essential two-component regulator in the human pathogen Staphylococcus aureus. WalKR regulates peptidoglycan synthesis, but this function alone does not explain its essentiality. Here, to further understand WalKR function, we investigate a suppressor mutant that arose when WalKR activity was impaired; a histidine to tyrosine substitution (H271Y) in the cytoplasmic Per-Arnt-Sim (PASCYT) domain of the histidine kinase WalK. Introducing the WalKH271Y mutation into wild-type S. aureus activates the WalKR regulon. Structural analyses of the WalK PASCYT domain reveal a metal-binding site, in which a zinc ion (Zn2+) is tetrahedrally-coordinated by four amino acids including H271. The WalKH271Y mutation abrogates metal binding, increasing WalK kinase activity and WalR phosphorylation. Thus, Zn2+-binding negatively regulates WalKR. Promoter-reporter experiments using S. aureus confirm Zn2+ sensing by this system. Identification of a metal ligand recognized by the WalKR system broadens our understanding of this critical S. aureus regulon.
- Published
- 2019
49. Remodeling of pSK1 Family Plasmids and Enhanced Chlorhexidine Tolerance in a Dominant Hospital Lineage of Methicillin-Resistant Staphylococcus aureus
- Author
-
Baines, SL, Jensen, SO, Firth, N, da Silva, AG, Seemann, T, Carter, GP, Williamson, DA, Howden, BP, Stinear, TP, Baines, SL, Jensen, SO, Firth, N, da Silva, AG, Seemann, T, Carter, GP, Williamson, DA, Howden, BP, and Stinear, TP
- Abstract
Staphylococcus aureus is a significant human pathogen whose evolution and adaptation have been shaped in part by mobile genetic elements (MGEs), facilitating the global spread of extensive antimicrobial resistance. However, our understanding of the evolutionary dynamics surrounding MGEs, in particular, how changes in the structure of multidrug resistance (MDR) plasmids may influence important staphylococcal phenotypes, is incomplete. Here, we undertook a population and functional genomics study of 212 methicillin-resistant S. aureus (MRSA) sequence type 239 (ST239) isolates collected over 32 years to explore the evolution of the pSK1 family of MDR plasmids, illustrating how these plasmids have coevolved with and contributed to the successful adaptation of this persistent MRSA lineage. Using complete genomes and temporal phylogenomics, we reconstructed the evolution of the pSK1 family lineage from its emergence in the late 1970s and found that multiple structural variants have arisen. Plasmid maintenance and stability were linked to IS256- and IS257-mediated chromosomal integration and disruption of the plasmid replication machinery. Overlaying genomic comparisons with phenotypic susceptibility data for gentamicin, trimethoprim, and chlorhexidine, it appeared that pSK1 has contributed to enhanced resistance in ST239 MRSA isolates through two mechanisms: (i) acquisition of plasmid-borne resistance mechanisms increasing the rates of gentamicin resistance and reduced chlorhexidine susceptibility and (ii) changes in the plasmid configuration linked with further enhancement of chlorhexidine tolerance. While the exact mechanism of enhanced tolerance remains elusive, this research has uncovered a potential evolutionary response of ST239 MRSA to biocides, one of which may contribute to the ongoing persistence and adaptation of this lineage within health care institutions.
- Published
- 2019
50. Capacity To Utilize Raffinose Dictates Pneumococcal Disease Phenotype
- Author
-
McDaniel, LS, Minhas, V, Harvey, RM, McAllister, LJ, Seemann, T, Syme, AE, Baines, SL, Paton, JC, Trappetti, C, McDaniel, LS, Minhas, V, Harvey, RM, McAllister, LJ, Seemann, T, Syme, AE, Baines, SL, Paton, JC, and Trappetti, C
- Abstract
Streptococcus pneumoniae is commonly carried asymptomatically in the human nasopharynx, but it also causes serious and invasive diseases such as pneumonia, bacteremia, and meningitis, as well as less serious but highly prevalent infections such as otitis media. We have previously shown that closely related pneumococci (of the same capsular serotype and multilocus sequence type [ST]) can display distinct pathogenic profiles in mice that correlate with clinical isolation site (e.g., blood versus ear), suggesting stable niche adaptation within a clonal lineage. This has provided an opportunity to identify determinants of disease tropism. Genomic analysis identified 17 and 27 single nucleotide polymorphisms (SNPs) or insertions/deletions in protein coding sequences between blood and ear isolates of serotype 14 ST15 and serotype 3 ST180, respectively. SNPs in raffinose uptake and utilization genes (rafR or rafK) were detected in both serotypes/lineages. Ear isolates were consistently defective in growth in media containing raffinose as the sole carbon source, as well as in expression of raffinose pathway genes aga, rafG, and rafK, relative to their serotype/ST-matched blood isolates. Similar differences were also seen between serotype 23F ST81 blood and ear isolates. Analysis of rafR allelic exchange mutants of the serotype 14 ST15 blood and ear isolates demonstrated that the SNP in rafR was entirely responsible for their distinct in vitro phenotypes and was also the determinant of differential tropism for the lungs versus ear and brain in a mouse intranasal challenge model. These data suggest that the ability of pneumococci to utilize raffinose determines the nature of disease.IMPORTANCES. pneumoniae is a component of the commensal nasopharyngeal microflora of humans, but from this reservoir, it can progress to localized or invasive disease with a frequency that translates into massive global morbidity and mortality. However, the factors that govern the switch from comm
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.